Education
About Us
Working with TipRanks
Follow Us
SAI Life Sciences Ltd. (IN:SAILIFE)
:SAILIFE
Total Valuation
SAI Life Sciences Ltd. has a market cap or net worth of ₹212.14B. The enterprise value is ₹214.07B.
Market Cap₹212.14B
Enterprise Value₹214.07B
Share Statistics
SAI Life Sciences Ltd. has 211,767,780 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding211,767,780
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
SAI Life Sciences Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 7.80%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)7.80%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee4.99M
Profits Per Employee669.52K
Employee Count3,401
Asset Turnover0.54
Inventory Turnover10.71
Valuation Ratios
The current PE Ratio of SAI Life Sciences Ltd. is 47.5. SAI Life Sciences Ltd.’s PEG ratio is 0.00.
PE Ratio47.5
PS Ratio8.60
PB Ratio6.85
Price to Fair Value6.85
Price to FCF-158.73
Price to Operating Cash Flow68.79
PEG Ratio0.00
Income Statement
In the last 12 months, SAI Life Sciences Ltd. had revenue of 16.96B and earned 1.70B in profits. Earnings per share was 8.83.
Revenue16.96B
Gross Profit6.19B
Operating Income2.73B
Pretax Income2.28B
Net Income1.70B
EBITDA4.42B
Earnings Per Share (EPS)8.83
Cash Flow
In the last 12 months, operating cash flow was 3.06B and capital expenditures -5.03B, giving a free cash flow of -1.98B billion.
Operating Cash Flow3.06B
Free Cash Flow-1.98B
Free Cash Flow per Share-9.34
Dividends & Yields
SAI Life Sciences Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.30
52-Week Price Change35.71%
50-Day Moving Average924.37
200-Day Moving Average869.58
Relative Strength Index (RSI)55.64
Average Volume (3m)11.95K
Important Dates
SAI Life Sciences Ltd. upcoming earnings date is May 19, 2026, During Market Hours (Confirmed).
Last Earnings DateFeb 5, 2026
Next Earnings DateMay 19, 2026
Ex-Dividend Date―
Financial Position
SAI Life Sciences Ltd. as a current ratio of 2.05, with Debt / Equity ratio of 24.83%
Current Ratio2.05
Quick Ratio1.89
Debt to Market Cap<0.01
Net Debt to EBITDA0.59
Interest Coverage Ratio3.49
Taxes
In the past 12 months, SAI Life Sciences Ltd. has paid 575.71M in taxes.
Income Tax575.71M
Effective Tax Rate0.25
Enterprise Valuation
SAI Life Sciences Ltd. EV to EBITDA ratio is 33.54, with an EV/FCF ratio of -161.58.
EV to Sales8.75
EV to EBITDA33.54
EV to Free Cash Flow-161.58
EV to Operating Cash Flow53.48
Balance Sheet
SAI Life Sciences Ltd. has ₹3.06B in cash and marketable securities with ₹5.64B in debt, giving a net cash position of -₹2.57B billion.
Cash & Marketable Securities₹3.06B
Total Debt₹5.64B
Net Cash-₹2.57B
Net Cash Per Share-₹12.15
Tangible Book Value Per Share₹109.92
Margins
Gross margin is 37.50%, with operating margin of 16.11%, and net profit margin of 10.03%.
Gross Margin37.50%
Operating Margin16.11%
Pretax Margin13.43%
Net Profit Margin10.03%
EBITDA Margin26.09%
EBIT Margin17.92%
Analyst Forecast
The average price target for SAI Life Sciences Ltd. is ₹1,300.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹1,300.00
Price Target Upside28.68% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―